BOSTON--(BUSINESS WIRE)--The Boston, MA law firm Shapiro Haber & Urmy LLP filed the class action securities fraud suit against InVivo Therapeutics Holdings Corp. (“InVivo”)(OTCBB: NVIV), a Cambridge, MA company, and its former Chairman and CEO for violations of federal securities laws on July 31, 2014. The firm filed the complaint in the United States District Court for the District of Massachusetts, entitled Battle Construction Co., Inc. v. InVivo Therapeutics Holdings Corp., et al., C.A. No. 14-cv-13180.
Shapiro Haber & Urmy LLP conducted a careful investigation before filing its Complaint, which alleges that the Defendants made false and misleading statements about the FDA’s approval of a clinical trial and the time for completion of the trial and submission of data to the FDA. The Complaint alleges that these misstatements and omissions by Defendants misrepresented and/or omitted material facts to the investing public, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act.
The class action is brought on behalf of all persons and entities who purchased common stock of InVivo during the period from April 5, 2013 through August 26, 2013.
If you would like more information about this case, you are interested in joining the suit, or you wish to register with the firm as a member of the class, please contact the firm at the telephone numbers below or by email.
The factual and legal bases for the Plaintiff’s claims are set forth in greater detail in the Complaint, which is available at www.shulaw.com. More information about the law firm and its qualifications is available at www.shulaw.com.
Several other law firms have published notices announcing the filing of a law suit against InVivo.
Shapiro Haber & Urmy LLP is the only firm that has investigated the company and has actually filed a complaint.
